by Waylon Wright | Jan 10, 2017
Next Tuesday, January 17th, join our Asia Pacific partner Brandwood Biomedical to learn about the strong yet complex medical technology market in Australia. With changes already announced to some prostheses prices, a Senate Inquiry, and the continuing reform of...
by Waylon Wright | Jan 5, 2017
The historic 21st Century Cures Act, written into law last December, is a 362-page bill comprised of several initiatives impacting the life sciences industry. The allocation of $4.8 billion for the “Cancer Moonshot” portion of the bill won over most headlines during...
by Waylon Wright | Dec 22, 2016
Over the past two weeks, the Pearl team celebrated the holiday season with various “12 Days of Christmas” activities. Events ranged from reindeer racing to gingerbread house building with plenty of company pitch-ins along the way. As 2016 winds down and...
by Waylon Wright | Dec 16, 2016
Record approvals of new drugs in 2014 and 2015 likely won’t continue in 2016. Even so, the total number of filings remains just above the average. FierceBiotech examined the numbers yesterday and tried to uncover the meaning. According to John Jenkins, the soon-to-be...
by Waylon Wright | Dec 15, 2016
Pearl Pathways announces the hiring of Waylon Wright as a Marketing and Sales Associate serving to expand the company’s commercialization efforts. Wright brings a diverse set of skills to the Pearl team, with over four years of sales, management, and marketing...
